Both PSR and EGAN acknowledge the importance of involving patient groups at an earl
...
Read more »
Services
PSR provides a full range of services for Orphan and related specialty drug development:
Follow us on:
News
03-02-2012 - PSR is part of two stage-2 FP7 applicationsPSR joined a total of two FP7 consortia for stage 2 of the 2012 FP7-HEALTH-20120-INNOVATION-1 call: preclinical an ... |
07-12-2011 - PSR to lead orphan drug MasterclassDr Anthony Hall, PSR’s Chief Medical Officer, will be leading an orphan drug Masterclass on 7th December 2011. ... |
01-02-2011 - PSR patients group EGAN sign intent to collaborate |
05-06-2010 - PSR launches new service: OrphanIQPRESS RELEASE Hoofddorp, The Netherlands, July 5, 2010 / – PSR announced today ... |
